Capital Flow Monitor · Sponsors · CIK 1932776
Stipple Bio, Inc.
238 Main Street, Cambridge, MA, 02142 · (646) 248-0890
Biotechnology · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$100.2M
Sold
$65.1M
% sold
65.0%
Investors
15
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-06 | D ·current | 506(b) | $100.2M | $65.1M | 65.0% | 15 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Jeffrey Landau — Executive Officer / Director, Cambridge, MA
-
Vineeta Agarwala — Director, Menlo Park, CA
3 other raises
- knownwell, inc. $26.1M of $26.1M · 100.0%
- Thyme Care, Inc. $97.0M of $100.0M · 97.0%
- Rezo Therapeutics, Inc. $68.1M of $80.1M · 84.9%
-
Owen Hughes — Director, Sudbury, MA
1 other raise
- Ikena Oncology, Inc. $0 of $75.0M · 0.0%
- Greg Verdine — Director, Boston, MA
- Aaron Ring — Director, Cambridge, MA
- Derek DiRocco — Director, Boston, MA
- Thilo Schroeder — Director, Grand Duchy of Luxembourg, N4
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.